Supplemental Filings: Califf Discusses Revolving Door; Poll Examines Public Trust In FDA Approvals - Pink Sheet

Commissioner Robert Califf continues to raise attention about what he terms the “revolving door for lawyers,” between the FDA and industry.

Agency staff leaving for jobs in the private sector is nothing new, but Califf mentioned during a speech at the Food and Drug Law Institute’s Annual Conference that the attention seems directed at departing scientists, rather than attorneys.

Read more